ERLOTINIB AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER AND NON-SQUAMOUS HISTOLOGY: A GALICIAN LUNG CANCER GROUP STUDY (GGCP041/09)

被引：0
|
作者：
Vazquez, S. [1 ]
Casal, Joaquin [2 ]
Firvida, J. L. [3 ]
Lazaro, Martin [2 ]
Varela, S. [1 ]
Jose Villanueva, Maria [2 ]
Garcia-Lopez, Jesus [3 ]
Campos, Begona [1 ]
Grande, C. [2 ]
Fernandez, Ovidio [3 ]
机构：
[1] Hosp Univ Lucus Augusti, Lugo, Spain
[2] Complexo Hosp Univ, Pontevedra, Spain
[3] Complexo Hosp Ourense, Med Oncol Serv, Orense, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Non-Small-Cell Lung Cancer; EGFR-TKI; Non-squamous histology;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1297 / S1297
页数：1
相关论文
共 50 条
  • [1] GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC).
    Vazquez Estevez, Sergio
    Villanueva Silva, Maria Jose
    Firvida Perez, Jose Luis
    Lazaro Quintela, Martin
    Varela Ferreiro, Silvia
    Huidobro Vence, Gerardo
    Fernandez Calvo, Ovidio
    Campos Balea, Begona
    Casal Rubio, Joaquin
    Areses Manrique, Carmen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC)
    Vazquez Estevez, S.
    Villanueva Silva, M. J.
    Firvida Perez, J. L.
    Lazaro Quintela, M.
    Varela Ferreiro, S.
    Huidobro Vence, G.
    Fernandez Calvo, O.
    Campos Balea, B.
    Grande Ventura, C.
    Areses, K.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S67 - S67
  • [3] Erlotinib as Frontline Treatment for Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) and Non-Squamous Histology - Results of a Galician Lung Cancer Group (GGCP044/09 Study) Grupo Galego De Cancro De Pulmon (GGCP)
    Firvidal, J. L.
    Vazquez, S.
    Casal, J.
    Fernandez, A.
    Varela, S.
    Villanueva, M. J.
    Perez, E.
    Campos, B.
    Salgado, M.
    Mel, J. R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S619 - S619
  • [4] Second-line erlotinib for non-small-cell lung cancer
    Lorusso, Vito
    Cinieri, Saverio
    LANCET ONCOLOGY, 2012, 13 (04): : E141 - E142
  • [5] ERLOTINIB AS FRONTLINE TREATMENT FOR ELDERLY PATIENTS (P) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): GGCP044/09 STUDY
    Firvida Perez, J. L.
    Vazquez Estevez, S.
    Casal Rubio, J.
    Alonso Bermejo, M.
    Varela Ferreiros, S.
    Villanueva Silva, M. J.
    Afonso Afonso, J.
    Fernandez Calvo, O.
    Areses, K.
    Campos Balea, B.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S71 - S71
  • [6] ERLOTINIB AS FRONTLINE TREATMENT FOR ELDERLY PATIENTS (P) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): GGCP044/09 STUDY
    Firvida, J. L.
    Vazquez, S.
    Casal, J.
    Alonso, M.
    Varela, S.
    Villanueva, M. J.
    Afonso, F. J.
    Fernandez, O.
    Areses, C.
    Campos, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 436 - 436
  • [7] Second-line erlotinib for non-small-cell lung cancer Reply
    Ciuleanu, Tudor
    LANCET ONCOLOGY, 2012, 13 (04): : E142 - E142
  • [8] Gemcitabine Plus Oral Vinorelbine as Salvage Therapy Treatment for Patients With Advanced Non-small-cell Lung Cancer and Squamous Histology - a Galician Lung Cancer Group Study (GGCP042/09) Grupo Galego De Cancro De Pulmon (GGCP)
    Vazquez, S.
    Villanueva, M. J.
    Firvida, J. L.
    Lazaro, M.
    Campos, B.
    Grande, C.
    Fernandez, A.
    Varela, S.
    Casal, J.
    Perez, E.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S618 - S618
  • [9] Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer:: a phase II study of the Galician Lung Cancer Group (GGCP 006-00)
    Vázquez, S
    Grande, C
    Amenedo, M
    Fírvida, JL
    Lázaro, M
    Alonso, G
    Curiel, T
    Huidobro, G
    Mel, JR
    Ramos, M
    ANTI-CANCER DRUGS, 2004, 15 (05) : 489 - 494
  • [10] Second-line erlotinib in patients with advanced non-small-cell lung cancer: Subgroup analyses from the TRUST study
    Heigener, David F.
    Wu, Yi-Long
    van Zandwijk, Nico
    Mali, Pekka
    Horvvood, Keith
    Reck, Martin
    LUNG CANCER, 2011, 74 (02) : 274 - 279
12345